DEVELOPMENT OF A TABLET FORM OF LIU WEI DI HUANG EXTRACT

Abstract

Objective: Develop an effective and stable tablet form of Liu Wei Di Huang (LWDH).Methods: LWDH extract was obtained by decoction (TC) and reflux with water (WR). Extracts were concentrated and analyzed by HPLC-PDA using loganin as the bioactive marker. Adsorbents, tablet strength and friability, and tablet quality and stability were evaluated.Results: Extraction of LWDH formula from raw materials using WR yielded higher concentrations of loganin than TC. The best formulation of LWDH tablets included Avicel®PH101, corn starch, purified talcum, magnesium stearate and Cab-osil® with about 97.40% of the label amount of active marker. Excluding moisture from the product reduced marker degradation, suggesting a product shelf life 12+months. Finished tablets were uniform in weight, friability, disintegrated in<30 min, had good microbial and heavy metal contamination safety profiles and was stable.Conclusions: Extraction of LWDH formula using reflux with water produces higher yields than decoction. A suitable tablet formulation consists of dried water extract (38.83%), corn starch (29.13%), Avicel®PH101 (29.13%), purified talcum (0.97%), magnesium stearate (0.97%) and Cab-osil® (0.97%) prepared by wet granulation. Excluding moisture from the product reduces product degradation, suggesting a shelf life of 12+months. LWDH tablets avoid traditional formulation problems (high dosages, unacceptable taste and odor, lack of product uniformity, contamination with microorganisms and heavy metals), and are a good alternative for patients and TCM practitioners. 

Authors and Affiliations

Vorawut Jearasakulpol, Pramote Tipduangta, Supanimit Teekachunhatean, Natthakarn Chiranthanut, Sunee Chansakaow

Keywords

Related Articles

SCAVENGING OF FREE RADICALS AND TOTAL PHENOLS OF METHANOL EXTRACT OF AZIMA TETRACANTHA LAM

Objective: To report the antioxidant activity, phenolic acid profile of the Azima tetracantha methanolic extract and find the correlation between the total phenolic content and their relative antioxidant activityMethods:...

CEREBROPROTEIN HYDROLYSATE INDUCED SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS): A CASE REPORT

Cerebroprotein hydrolysate is a newer pharmacological neurotropic agent and considered as a promising therapeutic agent for dementia, Alzheimer’s disease, traumatic brain injury and acute ischaemic stroke. Studies reve...

A COMPARATIVE PHARMACOGNOSTICAL EVALUATION OF THREE BOTANICAL SOURCE PLANTS OF JIVANTI

Objective: This study was undertaken to carry out a comparative pharmacognostical evaluation of three botanical source plants used in the name of classical Ayurvedic drug Jivanti.Methods: Leaves of three source plants of...

SYNTHESIS AND CHARACTERIZATION OF SILVER NANOPARTICLES USING TABERNAEMONTANA DIVARICATA AND ITS CYTOTOXIC ACTIVITY AGAINST MCF-7 CELL LINE

Objective: Tabernaemontana divaricata a common garden plant on tropical countries has been used as a traditional medicine. There is an increasing commercial demand for nanoparticles due to their wide applicability in var...

DRUG UTILIZATION EVALUATION OF BENZODIAZEPINES IN A TERTIARY CARE HOSPITAL

Objective: To assess the rationale use of benzodiazepines among various departments in a multi-speciality hospital. Methods: A prospective study was conducted with a sample size of 200 for a period of six months. Data w...

Download PDF file
  • EP ID EP578565
  • DOI -
  • Views 65
  • Downloads 0

How To Cite

Vorawut Jearasakulpol, Pramote Tipduangta, Supanimit Teekachunhatean, Natthakarn Chiranthanut, Sunee Chansakaow (2015). DEVELOPMENT OF A TABLET FORM OF LIU WEI DI HUANG EXTRACT. International Journal of Pharmacy and Pharmaceutical Sciences, 7(7), 275-281. https://europub.co.uk/articles/-A-578565